News & Events about Magenta Therapeutics Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RUTH, MGTA, OPCH, AMED SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RUTH, MGTA, OPCH, AMED PR Newswire NEW YORK, May 4, 2023 NEW YORK, May 4, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the...
Shareholder Alert: Ademi LLP investigates whether Magenta Therapeutics, Inc. has obtained a Fair Price in its transaction with Dianthus Shareholder Alert: Ademi LLP investigates whether Magenta Therapeutics, Inc. has obtained a Fair Price in its transaction with Dianthus PR Newswire MILWAUKEE, May...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of Magenta Therapeutics, Inc. (NasdaqGM: MGTA) with Dianthus Therapeutics, Inc. pursuant to which Magenta shareholders are expected to own...
Magenta Therapeutics Inc(NASDAQ: MGTA) and privately-heldDianthus Therapeutics Inchave announced to merge in anread more...
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Magenta Therapeutics, Inc. (NASDAQ: MGTA) and Dianthus Therapeutics, Inc. is fair to Magenta shareholders. Upon completion of the proposed transaction, Magenta shareholders are expected to own approximately 21.3...